Biogen (NASDAQ:BIIB) Issues FY24 Earnings Guidance

Biogen (NASDAQ:BIIB – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $15.00-$16.00 for the period, compared to the consensus earnings per share estimate of $15.81. Biogen also updated its FY 2024 guidance to 15.000-16.000 EPS. Biogen Stock Down 1.6 % Shares […]

Related Keywords

Manhattan ,New York ,United States ,Germany ,Priya Singhal ,Robertw Baird ,Piper Sandler ,Stifel Nicolaus ,Securities Exchange Commission ,First Manhattan Co ,Alpha Paradigm Partners ,Sunbelt Securities Inc ,Harbour Investments Inc ,Morgan Stanley ,Altshuler Shaham Ltd ,Biogen Inc ,Nasdaq ,Get Free Report ,Stock Down ,Moderate Buy ,Exchange Commission ,Shaham Ltd ,Paradigm Partners ,Sunbelt Securities ,Biogen Daily ,Biogen ,Nasdaq Biib ,Biib ,Medical ,09062x10 ,Guidance ,Earnings ,Preannouncement ,